Ashish Kila of Perfect Group presented his in-depth investment thesis on Agro Tech Foods (India: ATFL) at Best Ideas 2021.

Thesis summary:

Ashish’s idea is based on Tom Russo’s twin philosophy of “capacity to suffer” and “capacity to reinvest.” Agro Tech Foods is a subsidiary of ITC Limited (India: ITC), a global food giant. The subsidiary is going through a metamorphosis from a commodity to branded food company.

Agro Tech Foods has a long compounding runway as it continues to launch branded food products from the parent portfolio. The management is extremely focused on their “right to win” before entering any category and has done an excellent job of building a diversified food portfolio. The company continues to experience tailwinds of in-home consumption.

The shares were recently available at an attractive valuation.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Ashish Kila is a rank holder CA and MBA from MDI Gurgaon. He has worked with leading investment banks like Goldman Sachs & Morgan Stanley in their equity research division and now is the Director at Perfect Group. Ashish looks after the strategic functions of the group and manages the family office fund. Ashish has over the years conducted seminars on value investing, leadership, productivity and startups (angel investing) in prominent institutions like IIM (Calcutta, Indore), ISB (Hyderabad, Mohali), MDI Gurgaon, IBS Gurgaon, SSCBS, DSE, etc; forums like Octoberquest, MOI Global, CFA Society India; institutional firms like Fidelity, BNP Paribas MF, SBI MF, BOI AXA MF, Ambit House. Ashish & his family undertake social initiatives via the group’s NGO – Perfect Foundation which manages two projects under the aegis of Bhaorao Deoras Sewa Nyas, feeding 2000 people every day free of cost & managing the 300-bed patient attendant facility at AIIMS Trauma Centre.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.